SHANG Chen, SHUAI Yuan, YING Yingqiu, et al. Analysis on Rationality of Ertapenem in 300 Inpatients[J]. 2021,21(4):478-480. DOI: 10.14009/j.issn.1672-2124.2021.04.022.
OBJECTIVE: To investigate the application of ertapenem in inpatients of Peking University Third Hospital( hereinafter referred to as "our hospital")
so as to evaluate the rationality of medication and analyze the reasons. METHODS: The retrospective study method were used to obtain 300 medical records of inpatients receiving ertapenem in our hospital from Apr. 2018 to Mar. 2019. Based on the Guidelines for Clinical Application of Antibiotics( 2015 Edition)
relevant guidelines and expert consensus
statistical analysis was performed on indications
microbiological examination submission
usage and dosage
and drug combination. Rationality of medication and its related influencing factors were evaluated. RESULTS: Among the 300 inpatients receiving ertampenem
42 cases( 14. 00%) received perioperative prophylactic drugs. There were 258 cases( 86. 00%) of therapeutic drugs
among which 208 cases received microbiological examination
and 111 cases( 53. 37% of the total number of microbiological examination) were submitted for microbiological examination before therapeutic drugs. There were 238 cases of rational drug application
with the rational rate of 79. 33%. The main manifestations of irrational drug application were high starting point of antibiotics
long duration of treatment and inappropriate drug combination. Factors influencing the application rationality of ertapenem included the clinical pharmacist intervention( P < 0. 05) and department types( P< 0. 001). CONCLUSIONS: The application of ertapenem in our hospital is still irrational
intervention management needs to be further strengthened to promote the rational application of ertapenem in clinic.